Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs Lyfe Rx

Enhance MD
Graded #9

Higher grade

vs+28.9
Lyfe Rx
Graded #469

Lower grade

The verdict

Enhance MD takes it — 84.8/100 to 55.9/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnhance MD +32
82
50
Dose & formulationEnhance MD +18
82
64
Clinical oversightEnhance MD +33
88
55
Labs & monitoringEnhance MD +38
90
52
FulfillmentEnhance MD +22
84
62
Contract termsEnhance MD +29
84
55
Enhance MD · left barLyfe Rx · right bar

The numbers

MetricEnhance MDLyfe Rx
WeighScore84.8/10055.9/100
GradeBC
Scorecard rank#9#469
Semaglutide$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay$225/mo (compounded)
Tirzepatide$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay$299/mo (compounded)
CoverageNot publicly listedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Enhance MD

Graded #9 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs
Lyfe Rx

Graded #469 · C

FDAWarning letter issued to Lyfe Rx in September 2025. See the FDA warning-letter database.

Strengths

  • Both compounded semaglutide and tirzepatide available
  • Delivery to all 50 states with 1–3 day pharmacy turnaround

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • Also sells non-prescription supplements ('Tirzepatide Weight Loss Supplement', 'Lipo Burn')
  • Shopify-based e-commerce storefront — less clinical infrastructure
  • FDA issued Lyfe Rx a warning letter in September 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard